SCHEMBL23601716

SCHEMBL23601716

CN(c1cc(F)cc(CCC(C)(C)C(F)(F)F)c1)c1nc2nncn2c2cccc(F)c12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23601526 0.84 SMN1; SMN2 (0.30) SMN1; SMN2
SCHEMBL23601732 0.81
SCHEMBL23601251 0.80 MAPT (0.35) SMN1; SMN2
SCHEMBL23601717 0.80
SCHEMBL23601436 0.78 CRY1 (0.31)
SCHEMBL23601422 0.78
SCHEMBL23601730 0.77 SMN1; SMN2 (0.30) SMN1; SMN2
SCHEMBL23601681 0.77
SCHEMBL23577269 0.76 MAPT (0.37) SMN1; SMN2
SCHEMBL30961030 0.76 MAPT (0.37) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed